Titan Pharmaceuticals Inc. (TTNP)

New Form 8-K - TITAN PHARMACEUTICALS INC Filed: 2025-06-27 AccNo: 0001829126-25-004764 Size: 749 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits